FINELINE II
Report
- Report Number
- 2124215-2011-10103
- Event Type
- Injury
- Date Received
- July 22, 2011
- Date of Event
- June 8, 2011
- Report Date
- November 8, 2011
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVN
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
Narratives
UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, THE DEVICE WAS THOROUGHLY INSPECTED AND ANALYZED. A FRACTURE WAS CONFIRMED 180MM FROM THE TERMINAL PIN. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
ALL AVAILABLE INFORMATION INDICATES THAT THE LEAD REMAINS IN SERVICE. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
AT THIS TIME, THE LEAD HAS NOT BEEN RETURNED TO BOSTON SCIENTIFIC FOR ANALYSIS. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
FURTHER TESTING OBSERVED THAT A MARK WAS PRESENT ON THE LEAD AT 159 MM WHICH WAS MOST LIKELY THE PROXIMAL END OF THE SUTURE SLEEVE AND SUTURE TIE-DOWN SITES AT 167 AND 176 MM INDICATE THE APPROXIMATE IMPLANTED POSITION OF THE SUTURE SLEEVE. THE CONDUCTOR COIL WAS FRACTURED AT 180 MM WHICH LIKELY CORRESPONDS TO THE DISTAL PORTION OF THE SUTURE SLEEVE POSITION. FATIGUE WAS OBSERVED ON BOTH WIRE FRACTURES ALONG WITH TITANIUM RICH INCLUSIONS AT THE ORIGINS OF EACH FRACTURE.
THE RA LEAD WAS RETURNED TO ALLOW FOR RELIABILITY ANALYSIS.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT RIGHT ATRIAL (RA) PACING IMPEDANCE MEASUREMENTS WERE GREATER THAN 2,500 OHMS. THE LEAD SAFETY SWITCH WAS FOUND TO BE FLIPPED AND NO SENSING OR PACING WAS OBSERVED IN THE UNIPOLAR OR BIPOLAR MODE. THE PHYSICIAN REPROGRAMMED THE DEVICE TO VVI. TO DATE, NO ADVERSE PATIENT EFFECTS WERE REPORTED WITH THIS CLINICAL OBSERVATION.
AN INVASIVE REPOSITIONING PROCEDURE WAS PERFORMED DUE TO A SUSPECTED LEAD FRACTURE. THE RA LEAD WAS SUCCESSFULLY EXPLANTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED DURING THE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | FINELINE II | IMPLANTABLE LEAD | NVN | CPI - DEL CARIBE | 4472 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 62 YR | Hospitalization| R | 4473| 4472| 1291 |